What You Ought to Know:
– Eko, a cardiopulmonary digital well being firm launches its next-generation Eko DUO, an FDA-cleared cardiac evaluation instrument that features as an electrocardiogram (ECG) and digital stethoscope to detect early indicators of coronary heart illness and facilitate well timed care and customized illness administration.
– DUO is a pocket-sized cardiac examination system for clinicians used to detect early indicators of coronary heart illness and facilitate well timed take care of sufferers out and in of the clinic. Frontline clinicians can now view or reside stream ECG tracings and sound waveforms immediately from their cellular units with only a few faucets.
All-in-one Cardiac Examination System
By combining ECG and auscultation, clinicians get extra data at a look with out disrupting workflow or operating pricey exams. FDA-cleared software program permits clinicians to seize, transmit, and analyze electromechanical cardiac knowledge in as little as 15 seconds — from the clinic or the consolation of sufferers’ houses.
Objective-built for wi-fi listening and recording — each in-person and by way of telehealth — DUO is right for clinicians who must be cellular or work exterior of regular medical environments. Its unobtrusive type issue makes it straightforward for clinicians to ship care in each medical and non-clinical environments like residential care amenities or a affected person’s own residence.
Different options embody:
– See and listen to coronary heart, lung, and bowel sounds and ECG in real-time for extra well timed, knowledgeable decision-making. Provoke distant auscultation for telemedicine exams over a devoted
– HIPAA-compliant and encrypted reside stream with only a few clicks.
– Save limitless recordings to chronicle a affected person’s historical past or monitor illness development on a unified cloud dashboard.
– Securely share recordings for a second opinion or referral in only a few seconds.
– Entry superior audio controls to fine-tune your listening expertise.
Eko’s automated illness detection software program, powered by FDA-cleared, clinically confirmed synthetic intelligence (AI) algorithms, helps clinicians detect coronary heart murmurs and atrial fibrillation with comparable accuracy to human specialists. Most just lately, real-world validation for Eko’s coronary heart murmur detection algorithm got here from a peer-reviewed publication within the Journal of the American Coronary heart Affiliation.
“The following era DUO is a crucial part of the great platform for digital cardiopulmonary care that we’re constructing,” mentioned Connor Landgraf, CEO and co-founder of Eko. “A very powerful weapon we’ve towards coronary heart illness is knowledge and data. When we’ve details about how our coronary heart is functioning, that’s the weapon that helps us battle this illness extra successfully.”
